NasdaqGM - Nasdaq Real Time Price USD

Keros Therapeutics, Inc. (KROS)

14.02
+0.31
+(2.26%)
At close: May 8 at 4:00:00 PM EDT
14.35
+0.33
+(2.35%)
After hours: May 8 at 7:12:39 PM EDT

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

35.3

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
CTXR Citius Pharmaceuticals, Inc. 35 -- -- --
PMVP PMV Pharmaceuticals, Inc. 35 -- -- --
KROS Keros Therapeutics, Inc. 35 -- -- --
LUPIN.NS LUPIN LIMITED 35 5 17 13
SHJBF SHJBF 34 2 23 9

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 4/2025
KROS
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers